{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T23:13:03Z","timestamp":1725145983445},"reference-count":36,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0378","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T17:09:20Z","timestamp":1488820160000},"page":"431-436","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between asymmetric dimethylarginine in umbilical cord plasma and birth weight follows a U-shaped curve"],"prefix":"10.1507","volume":"64","author":[{"given":"Junji","family":"Takaya","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kawachi General Hospital, Higashi-Osaka 578-0954, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kansai Medical University, Hirakata 573-1010, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kuroyanagi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kansai Medical University, Hirakata 573-1010, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kansai Medical University, Hirakata 573-1010, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yi FX, Magness RR, Bird IM (2005) Simultaneous imaging of [Ca<sup>2+<\/sup>]<sub>i<\/sub> and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy. <i>Am J Physiol Regul Integr Comp Physiol<\/i> 288: R140-148.","DOI":"10.1152\/ajpregu.00302.2004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. B&ouml;ger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the &ldquo;L-arginine paradox&rdquo; and acts as a novel cardiovascular risk factor. <i>J Nutr<\/i> 134: 2842S-2847S.","DOI":"10.1093\/jn\/134.10.2842S"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Huang LT, Hsieh CS, Chang KA, Tain YL (2012) Roles of nitric oxide and asymmetric dimethylarginine in pregnancy and fetal programming. <i>Int J Mol Sci<\/i> 13: 14606-14622.","DOI":"10.3390\/ijms131114606"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chen S, Li N, Deb-Chatterji M, Dong Q, Kielstein JT, <i>et al<\/i>. (2012) Asymmetric dimethyarginine as marker and mediator in ischemic stroke. <i>Int J Mol Sci<\/i> 13: 15983-16004.","DOI":"10.3390\/ijms131215983"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Huemer M, Simma B, Mayr D, M&uuml;hl A, Rami B, <i>et al<\/i>. (2011) Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children. <i>J Pediatr<\/i> 158: 602-606.e1.","DOI":"10.1016\/j.jpeds.2010.09.058"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS (1993) Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. <i>Lancet<\/i> 342: 242-243.","DOI":"10.1016\/0140-6736(93)92335-Q"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Holden DP, Fickling SA, Whitley GS, Nussey SS (1998) Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. <i>Am J Obstet Gynecol<\/i> 178: 551-556.","DOI":"10.1016\/S0002-9378(98)70437-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Laskowska M, Laskowska K, Oleszczuk J (2015) The relation of maternal serum eNOS, NOSTRIN and ADMA levels with aetiopathogenesis of preeclampsia and\/or intrauterine fetal growth restriction. <i>J Matern Fetal Neonatal Med<\/i> 28: 26-32.","DOI":"10.3109\/14767058.2014.900036"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Braekke K, Ueland PM, Harsem NK, Staff AC (2009) Asymmetric dimethylarginine in the maternal and fetal circulation in preeclampsia. <i>Pediatr Res<\/i> 66: 411-415.","DOI":"10.1203\/PDR.0b013e3181b33392"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vallance P, Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. <i>Arterioscler Thromb Vasc Biol<\/i> 24: 1023-1030.","DOI":"10.1161\/01.ATV.0000128897.54893.26"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Willeit P, Freitag D, Laukkanen JA, Chowdhury S, Gobin R, <i>et al<\/i>. (2015) Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. <i>J Am Heart Assoc <\/i> 4: e001833.","DOI":"10.1161\/JAHA.115.001833"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Borgeraas H, Hertel JK, Svingen GF, Pedersen ER, Seifert R, <i>et al<\/i>. (2016) Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris. <i>PLoS One<\/i> 11: e0152029.","DOI":"10.1371\/journal.pone.0152029"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sibal L, Agarwal SC, Home PD, Boger RH (2010) The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. <i>Curr Cardiol Rev<\/i> 6: 82-90.","DOI":"10.2174\/157340310791162659"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cooke JP (2000) Does ADMA cause endothelial dysfunction? <i>Arterioscler Thromb Vasc Biol<\/i> 20: 2032-2037.","DOI":"10.1161\/01.ATV.20.9.2032"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, <i>et al<\/i>. (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. <i>Am J Cardiol<\/i> 88: 1201-1203.","DOI":"10.1016\/S0002-9149(01)02063-X"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, <i>et al<\/i>. (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. <i>J Cardiovasc Pharmacol<\/i> 33: 652-658.","DOI":"10.1097\/00005344-199904000-00020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Takaya J, Tanabe Y, Kuroyanagi Y, Kaneko K (2015) Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children. <i>Endocr J<\/i> 62: 551-556.","DOI":"10.1507\/endocrj.EJ14-0521"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Barker DJ, Bull AR, Osmond C, Simmonds SJ (1990) Fetal and placental size and risk of hypertension in adult life. <i>BMJ<\/i> 301: 259-262.","DOI":"10.1136\/bmj.301.6746.259"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, <i>et al<\/i>. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. <i>BMJ<\/i> 303: 1019-1022.","DOI":"10.1136\/bmj.303.6809.1019"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Barker DJ (1995) Intrauterine programming of adult disease. <i>Mol Med Today<\/i> 1: 418-423","DOI":"10.1016\/S1357-4310(95)90793-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chiavaroli V, Diesse L, de Giorgis T, Giannini C, Marcovecchio ML, <i>et al<\/i>. (2014) Is asymmetric dimethylarginine associated with being born small and large for gestational age? <i>Antioxid Redox Signal<\/i> 20: 2317-2322.","DOI":"10.1089\/ars.2013.5787"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takaya J, Yamato F, Higashino H, Kobayashi Y (2004) Ralationship of intracellular magnesium of cord blood platelets to birth weight. <i>Metabolism<\/i> 53: 1544-1547.","DOI":"10.1016\/j.metabol.2004.06.021"},{"key":"23","unstructured":"23. Nishida H, Sakanoue M, Kurachi K, Asada A, Kubo S, <i>et al<\/i>. (1984) Fetal growth curve of Japanese. <i>Acta Neonat Jap<\/i> 20: 90-97 (Japanese Ministry of Health and Welfare Research Group 1983, revised in 1994) (In Japanese)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Simmons RA, Templeton LJ, Gertz SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. <i>Diabetes<\/i> 50: 2279-2286.","DOI":"10.2337\/diabetes.50.10.2279"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. B&ouml;ger RH, Diemert A, Schwedheim E, Luneburg N, Maas R, <i>et al<\/i>. (2010) The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. <i>Gynecol Obstet Invest<\/i> 69: 1-13.","DOI":"10.1159\/000245940"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chertow JH, Alkaitis MS, Nardone G, Ikeda AK, Cunnington AJ, <i>et al<\/i>. (2015) Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor\/ Substrate Homeostasis. <i>PLoS Pathog<\/i> 11: e1005119.","DOI":"10.1371\/journal.ppat.1005119"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kelm M (1999) Nitric oxide metabolism and breakdown. <i>Biochim Biophys Acta<\/i> 1411: 273-289.","DOI":"10.1016\/S0005-2728(99)00020-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Barker DJ (1998) In utero programming of chronic disease. <i>Clin Sci (Lond)<\/i> 95: 115-128.","DOI":"10.1042\/cs0950115"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pettitti DJ, Jovanovic L (2001) Birth weight as a predictor of type 2 diabetes mellitus: The U-shaped curve. <i>Curr Diab Rep<\/i> 1: 78-81.","DOI":"10.1007\/s11892-001-0014-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Harder T, Rodekampo E, Schellong K, Dudenhausen JW, Plagemann A (2007) Birth weight and subsequent risk of type 2 diabetes: a meta-analysis. <i>Am J Epidemiol <\/i>165: 849-857.","DOI":"10.1093\/aje\/kwk071"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kajantie E, Feldt K, R&auml;ikk&ouml;nen K, Phillips DI, Osmond C, <i>et al<\/i>. (2007) Body size at birth predicts hypothalamic-pituitary-adrenal axis response to psychosocial stress at age 60 to 70 years. <i>J Clin Endocrinol Metab<\/i> 92: 4094-4100.","DOI":"10.1210\/jc.2007-1539"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, <i>et al<\/i>. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. <i>J Clin Endocrinol Metab<\/i> 85: 2402-2410.","DOI":"10.1210\/jcem.85.7.6661"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shoji H, Watanabe A, Ikeda N, Mori M, Kitamura T, <i>et al<\/i>. (2016) Influence of gestational age on serum incretin levels in preterm infants. <i>J Dev Orig Health Dis<\/i> 7: 685-688.","DOI":"10.1017\/S2040174416000404"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ruan H, Dong LQ (2016) Adiponectin signaling and function in insulin target tissues. <i>J Mol Cell Biol<\/i> 8: 101-109.","DOI":"10.1093\/jmcb\/mjw014"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kajantie E, Hytinantti T, Hovi P, Andersson S (2004) Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. <i>J Clin Endocrinol Metab<\/i> 89: 4031-4036.","DOI":"10.1210\/jc.2004-0018"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Moonen RM, Huizing MJ, Cavallaro G, Gonz&aacute;lez-Luis GE, Bas-Su&aacute;rez P, <i>et al<\/i>. (2014) Plasma levels of dimethylarginines in preterm very low birth weight neonates: its relation with perinatal factors and short-term outcome. <i>Int J Mol Sci<\/i> 16: 19-39.","DOI":"10.3390\/ijms16010019"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/4\/64_EJ16-0378\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:32:19Z","timestamp":1568874739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/4\/64_EJ16-0378\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0378","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}